2 authorised products containing Belantamab Mafodotin, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| BLENREP 100 mg powder for concentrate for solution for infusion EU/1/25/1948/002 |
Belantamab Mafodotin | GlaxoSmithKline Trading Services Limited | โ |
| BLENREP 70 mg powder for concentrate for solution for infusion EU/1/25/1948/001 |
Belantamab Mafodotin | GlaxoSmithKline Trading Services Limited | โ |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 September 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (โAuthorised or Transfer Pending Productsโ), licensed CC BY 4.0, refreshed daily. Regulatory information only โ not medical advice.